FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:619-620 August 23, 2001 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: The article on temporal aspects of heparin-induced thrombocytopenia (April 26 issue)¹ lacks some information that would be helpful. In particular, there is no mention of the type of heparin used in the initial treatment. In addition, the authors do not note how many patients, when treated again, were treated with the same or a different preparation of heparin.

It has been stated that the incidence of heparin-induced thrombocytopenia is lower in patients treated with low-molecular-weight heparin than in those treated with formulations of unfractionated heparin. It has also been stated that patients who have heparin-induced thrombocytopenia when . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.